{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:59:54Z","timestamp":1780639194623,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.drudis.2025.104481","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:22:17Z","timestamp":1758774137000},"page":"104481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA virus and DNA virus initiations of autoimmune diseases and\/or dementias"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-9835","authenticated-orcid":false,"given":"Kevin","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104481_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578314","article-title":"EBV infected cells in the multiple sclerosis brain express PD-L1: how the virus and its niche may escape immune surveillance","volume":"389","author":"Serafini","year":"2024","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.drudis.2025.104481_b0010","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s13577-023-00862-1","article-title":"Hyperinflammatory disease and vasculitis-associated autoimmune disease pathogenesis by novel virulent pathogens inducing lymphocyte exhaustion and\/or suppression","volume":"36","author":"Roe","year":"2023","journal-title":"Hum Cell"},{"key":"10.1016\/j.drudis.2025.104481_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0020","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/JLB.4MR0620-091R","article-title":"Unraveling exhaustion in adaptive and conventional NK cells","volume":"108","author":"Merino","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2025.104481_b0025","first-page":"1","article-title":"NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion \u2013 the differences and similarities","volume":"00","author":"Roe","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2025.104481_b0030","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1038\/cti.2016.87","article-title":"Defective T\u2010cell control of Epstein\u2013Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein\u2013Barr virus","volume":"152","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2025.104481_b0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00980-19","article-title":"Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven immunopathological mechanism","volume":"93","author":"Serafini","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104481_b0045","article-title":"Broader Epstein\u2013Barr virus\u2013specific T cell receptor repertoire in patients with multiple sclerosis","volume":"219","author":"Schneider-Hohendorf","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.drudis.2025.104481_b0050","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/s41467-018-07053-9","article-title":"Tissue-resident memory T cells populate the human brain","volume":"9","author":"Smolders","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104481_b0055","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2025.104481_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578036","article-title":"Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells","volume":"376","author":"Serafini","year":"2023","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.drudis.2025.104481_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad206","article-title":"Regulation of the programmed cell death protein 1\/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis","volume":"5","author":"Tsaktanis","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.drudis.2025.104481_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12985-020-01302-4","article-title":"Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy","volume":"17","author":"Handous","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.drudis.2025.104481_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fmed.2020.00188","article-title":"Cytomegalovirus: a troll in the ICU? Overview of the literature and perspectives for the future","volume":"7","author":"Schildermans","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.drudis.2025.104481_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1385233","article-title":"EBV and multiple sclerosis: expression of LMP2A in MS patients","volume":"18","author":"Agostini","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/microorganisms12020362","article-title":"From viral infection to autoimmune reaction: exploring the link between human herpesvirus 6 and autoimmune diseases","volume":"12","author":"Sokolovska","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.drudis.2025.104481_b0090","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","article-title":"Virus exposure and neurodegenerative disease risk across national biobanks","volume":"111","author":"Levine","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2025.104481_b0095","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","article-title":"Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort","volume":"21","author":"Sipil\u00e4","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fncel.2019.00046","article-title":"Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders","volume":"13","author":"Duarte","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0105","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760220200","article-title":"Family Herpesviridae and neuroinfections: current status and research in progress","volume":"117","author":"Carneiro","year":"2022","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.drudis.2025.104481_b0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12026-023-09377-1","article-title":"A latent pathogen infection classification system that would significantly increase healthcare safety","volume":"71","author":"Roe","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.drudis.2025.104481_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31083\/j.jin2102073","article-title":"Infectious agents and Alzheimer's disease","volume":"21","author":"Piekut","year":"2022","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0120","article-title":"Infection and immune control of human oncogenic \u03b3-herpeviruses in humanized mice","volume":"374","author":"McHugh","year":"2019","journal-title":"Philo Tran R Soc Lond B Biol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0125","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","article-title":"Pathogenesis and virulence of herpes simplex virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.drudis.2025.104481_b0130","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1038\/s41598-021-87963-9","article-title":"Herpes simplex virus 1 and the risk of dementia: a population-based study","volume":"11","author":"Murphy","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104481_b0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/alz.13414","article-title":"DNA from multiple viral species is associated with Alzheimer's disease risk","volume":"20","author":"Tejeda","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2025.104481_b0140","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41398-021-01532-2","article-title":"Herpes simplex virus, early neuroimaging markers and incidence of Alzheimer\u2019s disease","volume":"11","author":"Linard","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2025.104481_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2025.104481_b0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2021.11.004","article-title":"Beneficial and detrimental functions of microglia during viral encephalitis","volume":"45","author":"Waltl","year":"2022","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102161","article-title":"Once upon a time, the amyloid cascade hypothesis","volume":"93","author":"Granzotto","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.drudis.2025.104481_b0160","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Eng J Med"},{"key":"10.1016\/j.drudis.2025.104481_b0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2025.104481_b0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/biom13030453","article-title":"The amyloid cascade hypothesis in Alzheimer's disease: should we change our thinking?","volume":"13","author":"Kurkinen","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104481_b0175","doi-asserted-by":"crossref","first-page":"11720","DOI":"10.3390\/ijms252111720","article-title":"From plaques to pathways in Alzheimer\u2019s disease: the mitochondrial-neurovascular-metabolic hypothesis","volume":"25","author":"Kazemeini","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0180","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.931821","article-title":"Encephalitis due to co-infection with cytomegalovirus and herpes simplex virus type 2 in a patient with acquired immunodeficiency syndrome","volume":"22","author":"Zahid","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.drudis.2025.104481_b0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/qjmed\/hcac060","article-title":"Post-COVID-19 HSV encephalitis: a review","volume":"115","author":"Gupta","year":"2022","journal-title":"QJM"},{"key":"10.1016\/j.drudis.2025.104481_b0190","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1212\/WNL.0000000000200709","article-title":"Incident herpes zoster and risk of dementia: a population-based Danish cohort study","volume":"99","author":"Schmidt","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2025.104481_b0195","article-title":"Hemorrhagic stroke due to varicella zoster virus vasculopathy","volume":"15","author":"Hofstrand","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.drudis.2025.104481_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106891","article-title":"Risk of, and risk factors for, vasculopathy associated with acute herpes zoster","volume":"32","author":"Yawn","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00848-24","article-title":"Suppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles","volume":"98","author":"Niemeyer","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104481_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012733","article-title":"Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles directing astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain","volume":"21","author":"Tabaie","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.drudis.2025.104481_b0215","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2025.104481_b0220","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes zoster and dementia: a nationwide population-based cohort study","volume":"79","author":"Chen","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.drudis.2025.104481_b0225","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.12659\/MSM.909596","article-title":"Age-related increase of insulin-degrading enzyme is inversely correlated with cognitive function in APPswe\/PS1dE9 mice","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.drudis.2025.104481_b0230","article-title":"Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer\u2019s disease: possible mechanisms of IDE in T2D and AD","volume":"38","author":"Li","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.drudis.2025.104481_b0235","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1042\/BST20190511","article-title":"Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis","volume":"48","author":"Oliver","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.drudis.2025.104481_b0240","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JVI.01801-09","article-title":"Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum","volume":"84","author":"Carpenter","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104481_b0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00406-019-00995-1","article-title":"Binding varicella zoster virus: an underestimated facet of insulin-degrading enzym\u00e9s implication for Alzheime\u0155s disease pathology?","volume":"270","author":"Bernstein","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0250","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/ijms24010884","article-title":"Microglial activation and priming in Alzheimer's disease: state of the art and future perspectives","volume":"24","author":"Bivona","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.21037\/atm.2018.04.22","article-title":"Microglial priming in Alzheimer\u2019s disease","volume":"6","author":"Li","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.drudis.2025.104481_b0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ibra.12090","article-title":"The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology","volume":"9","author":"Anwar","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.drudis.2025.104481_b0265","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/v15081663","article-title":"The spectrum of neurological manifestations of varicella-zoster virus reactivation","volume":"15","author":"Kennedy","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104481_b0270","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.052","article-title":"Varicella zoster virus: a common cause of stroke in children and adults","volume":"25","author":"Amlie-Lefond","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.745046","article-title":"The potential of ferroptosis-targeting therapies for Alzheimer\u2019s disease: from mechanism to transcriptomic analysis","volume":"13","author":"Majern\u00edkov\u00e1","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2025.104481_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101494","article-title":"Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer\u2019s disease: evidence of ferroptosis","volume":"32","author":"Ashraf","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.drudis.2025.104481_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1390798","article-title":"A critical appraisal of ferroptosis in Alzheimer\u2019s and Parkinson\u2019s disease: new insights into emerging mechanisms and therapeutic targets","volume":"15","author":"Soni","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104481_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.drudis.2025.104481_b0295","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/nipt-2023-0011","article-title":"The elusive role of herpesviruses in Alzheimer\u2019s disease: current evidence and future directions","volume":"2","author":"Piotrowski","year":"2023","journal-title":"NeuroImmune Pharm Ther"},{"key":"10.1016\/j.drudis.2025.104481_b0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.33597\/aimm.02-1007","article-title":"Alzheimer\u2019s disease is driven by intraneuronally retained beta-amyloid produced in the AD-specific, \u03b2APP-independent pathway: current perspective and experimental models for tomorrow","volume":"2","author":"Volloch","year":"2020","journal-title":"Ann Integr Mol Med"},{"key":"10.1016\/j.drudis.2025.104481_b0305","first-page":"75","article-title":"AD \u201cStatin\u201d: Alzheimer\u2019s disorder is a \u201cfast\u201d disease preventable by therapeutic intervention initiated even late in life and reversible at the early stages","volume":"2","author":"Volloch","year":"2020","journal-title":"Ann Integr Mol Med"},{"key":"10.1016\/j.drudis.2025.104481_b0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer's disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2025.104481_b0315","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","article-title":"Varicella zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-beta, and an amyloidogenic extracellular environment","volume":"221","author":"Bubak","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0320","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3389\/fmicb.2017.02521","article-title":"Beta and gamma human herpesviruses: agonistic and antagonistic interactions with the host immune system","volume":"8","author":"Cruz-Mu\u00f1oz","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104481_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101706","article-title":"Adaptive NK cell response to human cytomegalovirus: facts and open issues","volume":"65","author":"L\u00f3pez-Botet","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.847106","article-title":"Differential impacts of HHV-6A versus HHV-6B infection in differentiated human neural stem cells","volume":"13","author":"Bahramian","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13027-019-0248-3","article-title":"An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity","volume":"14","author":"Wells","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.drudis.2025.104481_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165647","article-title":"HHV-6A infection dysregulates autophagy\/UPR interplay increasing beta amyloid production and tau phosphorylation in astrocytoma cells as well as in primary neurons, possible molecular mechanisms linking viral infection to Alzheimer's disease","volume":"1866","author":"Romeo","year":"2020","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0345","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3390\/ijms22052250","article-title":"The association of human herpesviruses with malignant brain tumor pathology and therapy: two sides of a coin","volume":"22","author":"Athanasiou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology","volume":"13","author":"Hogestyn","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2025.104481_b0355","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00311-20","article-title":"gp96 is critical for both human herpesvirus 6A (HHV-6A) and HHV-6B infections","volume":"94","author":"Ma","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2025.104481_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1189805","article-title":"Hematopoietic stem cells and betaherpesvirus latency","volume":"13","author":"Crawford","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2025.104481_b0365","article-title":"Human herpes virus 7-related encephalopathy in children","volume":"92","author":"Foiadelli","year":"2022","journal-title":"Acta Biomed"},{"key":"10.1016\/j.drudis.2025.104481_b0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/brainsci10050287","article-title":"Persistent roseoloviruses infection in adult patients with epilepsy","volume":"10","author":"Rasa-Dzelzkaleja","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0375","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s13365-015-0417-0","article-title":"Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy","volume":"22","author":"Chapenko","year":"2016","journal-title":"J Neurovirol"},{"key":"10.1016\/j.drudis.2025.104481_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13365-016-0473-0","article-title":"Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals","volume":"23","author":"Ongr\u00e1di","year":"2017","journal-title":"J Neurovirol"},{"key":"10.1016\/j.drudis.2025.104481_b0385","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ddmod.2020.01.001","article-title":"Epstein-Barr virus infection in the development of neurological disorders","volume":"32","author":"Soldan","year":"2020","journal-title":"Drug Discov Today Dis Models"},{"key":"10.1016\/j.drudis.2025.104481_b0390","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.816098","article-title":"Epstein-Barr virus and neurological diseases","volume":"8","author":"Zhang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2025.104481_b0395","article-title":"Case report: Epstein-Barr virus encephalitis complicated with brain stem hemorrhage in an immune-competent adult","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0400","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2025.104481_b0405","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104481_b0410","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.drudis.2025.104481_b0415","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","article-title":"Attenuated immune control of Epstein\u2013Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15","volume":"51","author":"Zdimerova","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jneuroim.2017.07.013","article-title":"Antibodies to the Epstein\u2013Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins","volume":"310","author":"Lindsey","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.drudis.2025.104481_b0425","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between Anoctamin 2 and Epstein\u2013Barr virus nuclear antigen 1 associates with multiple sclerosis risk","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104481_b0430","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","article-title":"EBV-encoded latent genes","volume":"1045","author":"Kanda","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.drudis.2025.104481_b0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.830993","article-title":"A high prevalence of anti-EBNA1 heteroantibodies in systemic lupus erythematosus (SLE) supports anti-EBNA1 as an origin for SLE autoantibodies","volume":"13","author":"Laurynenka","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606936","article-title":"Epstein\u2013Barr functional mimicry: pathogenicity of oncogenic latent membrane protein-1 in systemic lupus erythematosus and autoimmunity","volume":"11","author":"Munroe","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104481_b0445","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","article-title":"Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis","volume":"72","author":"Croia","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.drudis.2025.104481_b0450","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/JLB.3MR0218-062R","article-title":"Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer","volume":"104","author":"Nerviani","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2025.104481_b0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s11658-022-00312-0","article-title":"Peptidylarginine deiminase 2 promotes T helper 17-like T cell activation and activated T cell-autonomous death (ACAD) through an endoplasmic reticulum stress and autophagy coupling mechanism","volume":"27","author":"Yang","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.drudis.2025.104481_b0460","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/biom14040400","article-title":"The role of citrullination modification in CD4+ T cells in the pathogenesis of immune-related diseases","volume":"14","author":"Chen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104481_b0465","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/his.14551","article-title":"Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders","volume":"79","author":"Granai","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.drudis.2025.104481_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104986","article-title":"Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients","volume":"100","author":"Lambarey","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2025.104481_b0475","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0275","article-title":"Kaposi sarcoma herpesvirus pathogenesis","volume":"372","author":"Mariggi\u00f2","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0480","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.3390\/ijms23137203","article-title":"Human gamma herpesvirus 8 oncogenes associated with Kaposi's sarcoma","volume":"23","author":"Lopes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104481_b0485","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/ijd.IJD_217_18","article-title":"The spectrum of underlying causes of iatrogenic Kaposi's sarcoma in a large series: a retrospective study","volume":"64","author":"Baykal","year":"2019","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.drudis.2025.104481_b0490","article-title":"Iatrogenic Kaposi sarcoma precipitated by anti-tumor necrosis factor-alpha (anti-TNF-\u03b1) therapy","volume":"13","author":"Mariappan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.drudis.2025.104481_b0495","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3390\/v14122709","article-title":"Co-infection of the Epstein-Barr virus and the Kaposi sarcoma-associated herpesvirus","volume":"14","author":"B\u00f6ni","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2025.104481_b0500","doi-asserted-by":"crossref","first-page":"16519","DOI":"10.1073\/pnas.1905025116","article-title":"How Kaposi\u2019s sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis","volume":"116","author":"Faure","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104481_b0505","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2017.06.009","article-title":"Persistent KSHV infection increases EBV-associated tumor formation in vivo via enhanced EBV lytic gene expression","volume":"22","author":"McHugh","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2025.104481_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109056","article-title":"KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV\/EBV dual infection","volume":"35","author":"Caduff","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2025.104481_b0515","doi-asserted-by":"crossref","first-page":"E11379","DOI":"10.1073\/pnas.1810128115","article-title":"Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus","volume":"115","author":"Bigi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2025.104481_b0520","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s13337-018-0481-1","article-title":"Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis","volume":"29","author":"Marashi","year":"2018","journal-title":"Virusdisease"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625001941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625001941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:03:24Z","timestamp":1780635804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625001941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":104,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1359644625001941"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104481","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA virus and DNA virus initiations of autoimmune diseases and\/or dementias","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104481"}}